Literature DB >> 24680118

[Bronchioloalveolar carcinoma: an exceptional cause of diffuse lung disease in a patient with acute myeloid leukemia].

A Boubaya1, E Gomez1, A Guerder1, H Ropion-Michaux2, A Kheir1, J-M Vignaud3, A Chaouat1, F Chabot4.   

Abstract

INTRODUCTION: Bronchiolo-alveolar carcinoma is a primary pulmonary adenocarcinoma developing in the terminal respiratory unit. CASE REPORT: An 84-year-old non-smoker woman with a history of untreated acute myeloid leukaemia was referred to the intensive care unit for pneumonia and acute respiratory failure. The patient reported dyspnoea and a productive cough for 3 months, treated by antibiotics and steroids without improvement. Thoracic CT-scan showed alveolar condensations and multiple nodular lesions. All microbiological samples were negative and the evolution was fatal within 72 hours despite empirical antibiotic therapy and noninvasive ventilation. Post-mortem lung biopsies gave a diagnosis of mucinous and non-mucinous bronchiolo-alveolar carcinoma with typical lepidic growth pattern of tumor cells and discrete septal thickening but no fibrosis, inflammation or local invasion.
CONCLUSION: Bronchiolo-alveolar carcinoma is an alternative diagnosis in alveolar condensations associated with pulmonary nodules even in a patient with immunosupression. Early diagnosis allows effective treatment in some cases.
Copyright © 2013 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukaemia; Acute respiratory failure; Bronchiolo-alveolar carcinoma; Carcinome bronchiolo-alvéolaire; Diffuse lung disease; Insuffisance respiratoire aiguë; Leucémie aiguë myéloïde; Pneumopathie diffuse

Mesh:

Year:  2013        PMID: 24680118     DOI: 10.1016/j.rmr.2013.07.003

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  1 in total

1.  Lung Cancer with Diffuse Ground-glass Shadow in Two Lungs and Respiratory Failure.

Authors:  Zhe-Min Feng; Zhen-Jie Zhuang; Wen-Bo He; Jian-Ping Ding; Wen-Jun Yang; Xue-Yuan Chen
Journal:  Chin Med J (Engl)       Date:  2016-08-05       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.